by Denise Purdie Andrews | Nov 29, 2022 | Drug Classes
Dr. George Behonick presented the following poster at the annual NAME meeting in Dallas, TX. This is the first of several articles to share recent presentations by our toxicologists. Postmortem Redistribution of Fentanyl as Evidenced by Central and Peripheral Blood...
by Denise Purdie Andrews | Oct 4, 2022 | Announcements
By Denise Purdie Andrews This Fall, Axis’ expert toxicologists can be found speaking in several different venues, helping to educate our clients and share expertise with other forensic scientists. Last month, George S. Behonick, PhD, presented at the Indiana...
by Denise Purdie Andrews | Aug 18, 2022 | Announcements
Dear Valued Client, In the spirit of continual improvement and to provide our clients with industry leading service, we are excited to announce an upcoming change in testing associated with our 42130: Synthetic Cannabinoids Panel. While these types of compounds have...
by Denise Purdie Andrews | Aug 18, 2022 | Announcements
Dear Valued Client, In the spirit of continual improvement and to provide our clients with industry leading service, we are excited to announce an upcoming change in testing associated with our 32400: Electrolyte Panel. For years this testing has been a referred test...
by Denise Purdie Andrews | Aug 8, 2022 | General
By Kevin Shanks, M.S., D-ABFT-FT We talk about false positives in forensic toxicology a lot. Could a specific drug cause a false positive for another drug on a toxicology test? The answer is a bit complex, but it is both yes and no. First, we need to talk about the...
by Denise Purdie Andrews | Jul 14, 2022 | General
By Kevin Shanks, D-ABFT-FT In toxicology testing, qualitative and quantitative testing are the norm, but every so often something prevents a result from being acquired. This “something” is called interference and will be displayed on the Axis Forensic Toxicology...
by Denise Purdie Andrews | Jun 9, 2022 | Drug Classes
By Kevin Shanks, D-ABFT-FT Over the last several years, the Drug Enforcement Administration (DEA) has moved to ban various newly emerged illicit opioids as Schedule I controlled substances. From 2015-2017, they controlled 19 fentanyl analogs and other opioids. In...
by Denise Purdie Andrews | May 23, 2022 | Announcements
Dear Valued Client, In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in...
by Denise Purdie Andrews | May 9, 2022 | Drug Classes
By Kevin Shanks, D-ABFT-FT Mitragyna speciosa is a tree or shrub that grows in southeast Asia, particularly Thailand and Malaysia. The plant is locally known as kratom or biak-biak. It exists in the Rubiaceae family of plants, which includes the genera Coffea or...
